|
AU5588298A
(en)
|
1996-12-02 |
1998-06-29 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated delivery of dna to cells of the liver
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
CA2392863A1
(en)
|
2002-07-08 |
2004-01-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A high capacity recombinant adenoviral vector for treatment of hemophilia a
|
|
PL1675956T3
(pl)
|
2003-10-21 |
2011-06-30 |
Merck Serono Sa |
Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
|
|
JPWO2006043354A1
(ja)
|
2004-10-20 |
2008-05-22 |
独立行政法人放射線医学総合研究所 |
組込型の低線量放射線誘導性ベクター
|
|
MX2007015540A
(es)
|
2005-06-10 |
2008-03-07 |
Genentech Inc |
Mejora de la expresion de anticuerpos utilizando vectores que contienen elementos aislantes.
|
|
CN101965409A
(zh)
|
2007-11-01 |
2011-02-02 |
罗切斯特大学 |
具有增加的稳定性的重组因子viii
|
|
EP4154903A1
(en)
|
2008-04-22 |
2023-03-29 |
Vib Vzw |
Liver-specific nucleic acid regulatory elements and methods and use thereof
|
|
WO2009134681A2
(en)
*
|
2008-04-30 |
2009-11-05 |
The Trustees Of The University Of Pennsylvania |
Aav7 viral vectors for targeted delivery of rpe cells
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
AU2012312260B2
(en)
*
|
2011-09-21 |
2017-08-31 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of transgene expression
|
|
CN104114572A
(zh)
*
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
DK2804623T3
(da)
|
2012-01-12 |
2019-11-11 |
Bioverativ Therapeutics Inc |
Kimære faktor viii-polypeptider og anvendelser deraf
|
|
DK3444342T3
(da)
|
2012-07-11 |
2020-08-24 |
Sangamo Therapeutics Inc |
Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme
|
|
JP2015529466A
(ja)
|
2012-09-14 |
2015-10-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター
|
|
EP2911687B1
(en)
|
2012-10-26 |
2019-02-13 |
Vrije Universiteit Brussel |
Vector for liver-directed gene therapy of hemophilia and methods and use thereof
|
|
BR112015025041A2
(pt)
|
2013-03-30 |
2017-09-12 |
Usha Biotech Ltd |
métodos e conceitos para expressar proteínas biologicamente ativas em células de mamíferos
|
|
RS61039B1
(sr)
|
2013-09-12 |
2020-12-31 |
Biomarin Pharm Inc |
Aav vektori koji sadrže gen koji kodira faktor viii
|
|
DK3080274T3
(da)
|
2013-12-09 |
2020-08-31 |
Sangamo Therapeutics Inc |
Fremgangsmåder og sammensætninger til genom-manipulation
|
|
AU2015204646B2
(en)
|
2014-01-10 |
2020-08-27 |
Bioverativ Therapeutics Inc. |
Factor VIII chimeric proteins and uses thereof
|
|
KR102554850B1
(ko)
|
2015-02-06 |
2023-07-13 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도
|
|
CN115074366A
(zh)
*
|
2015-04-16 |
2022-09-20 |
埃默里大学 |
用于肝脏中蛋白质表达的重组启动子和载体及其用途
|
|
WO2016180755A1
(en)
|
2015-05-11 |
2016-11-17 |
Bayer Cropscience Aktiengesellschaft |
Herbicide combinations comprising l-glufosinate and indaziflam
|
|
EP3322297B1
(en)
|
2015-07-13 |
2024-12-04 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
RU2742352C2
(ru)
|
2015-09-24 |
2021-02-05 |
Байомарин Фармасьютикал Инк. |
Векторы фактора fviii на основе аденоассоциированных вирусов, соответствующие вирусные частицы и содержащие их терапевтические композиции
|
|
CA3002524A1
(en)
|
2015-10-28 |
2017-05-04 |
Sangamo Therapeutics, Inc. |
Liver-specific constructs, factor viii expression cassettes and methods of use thereof
|
|
EP3374387A1
(en)
*
|
2015-11-13 |
2018-09-19 |
Baxalta Incorporated |
Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
|
|
AU2018312565A1
(en)
*
|
2017-08-01 |
2020-02-27 |
Spark Therapeutics, Inc. |
Factor VIII (FVIII) gene therapy methods
|